Novartis said it has appointed a senior Merck executive to run its cancer business, filling the top spot at one of the company's most important franchises.
from WSJ.com: US Business http://ift.tt/1oLduhj
via IFTTT
from WSJ.com: US Business http://ift.tt/1oLduhj
via IFTTT
No comments:
Post a Comment